Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-03-21 @ 9:16 PM
Study NCT ID:
NCT00499603
Status:
UNKNOWN
Last Update Posted:
2016-11-01
First Post:
2007-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Breast Cancer | View |
| None | ER negative | View |
| None | PR negative | View |
| None | HER2neu negative | View |
| None | Tumor Triple Negative Receptors | View |
| None | Paclitaxel | View |
| None | Taxol | View |
| None | RAD001 | View |
| None | FEC | View |
| None | 5-Fluorouracil | View |
| None | 5-FU | View |
| None | Adrucil | View |
| None | Efudex | View |
| None | Epirubicin | View |
| None | Cyclophosphamide | View |